Market revenue in 2020 | USD 29.6 million |
Market revenue in 2028 | USD 57.4 million |
Growth rate | 8.6% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 66.55% in 2020. Horizon Databook has segmented the UAE chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Being a high-income country, the UAE government aims to provide universal access to updated and advanced healthcare services. Due to its vast financial resources and adequate government funding, the UAE chemiluminescence immunoassay market is steadily growing.
In addition, ongoing public-private initiatives to facilitate diagnosis of chronic diseases in the country are expected to create supportive environment for growth. For instance, in October 2020, Biogenix Labs, in association with Abu Dhabi Quality and Conformity Council, began the Proficiency Testing Program for COVID-19 external testing procedures.
Biogenix Labs’ state-of-the-art equipment includes fully automated immunoassay, real-time PCR, and extractors. In addition, in 2019, Cleveland Clinic Abu Dhabi announced introduction of an enhanced range of liver cancer services in the country to address the growing demand.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into UAE chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account